The claim that IPOPs priced IPO stocks 10.8% to 38.4% below the eventual listing price is not just a statistic—it's a declaration of war on the traditional IPO underwriting model. That delta is the central exhibit in a comment letter submitted by Hyperliquid Policy Center (HPC) and market maker trade[XYZ] to the SEC, proposing a regulatory framework for pre-IPO perpetual contracts (IPOPs). The data, however, is self-reported. The sample size is five markets. The architect is a single market maker. And the product—a synthetic asset that mimics a stock's price without conferring any ownership—sits in a jurisdictional grey zone between the SEC and CFTC. This is not a technical breakthrough. It is a structural pre-mortem on whether DeFi can force a seat at the table of capital formation regulation.
Context: The Players and the Product
Hyperliquid Policy Center (HPC) is the official advocacy arm of the Hyperliquid ecosystem. trade[XYZ] is a market maker that has operated five IPOP markets to completion on Hyperliquid's L1 chain. The product itself is a perpetual swap that tracks the price of an upcoming IPO stock—but crucially, it grants no shares, no warrants, no voting rights, and no claim on the issuer. It is a synthetic asset by design, engineered to avoid the Howey test's third prong (profit from the efforts of others). The legal theory is that IPOPs are event contracts: the event is the IPO listing price, and the contract settles to that price. No delivery, no security.
Yet the SEC's request for comment on the proposal—and HPC's decision to engage—signals that the regulator sees this as more than a prediction market. The IPOP's price discovery function is precisely what creates the regulatory risk. Traditional IPO pricing is an opaque process led by underwriters who intentionally underprice to ensure a first-day pop. IPOPs offer a continuous, transparent alternative. That threatens the status quo.
Core: The On-Chain Evidence Chain
Let me be clear: I have audited the vesting schedules of over 50 ICO projects in 2017. I have traced the on-chain forensics of the Terra-LUNA collapse. I know data when I see it—and the data here is thin. The 10.8% to 38.4% discount range is derived from five markets, all operated by trade[XYZ]. No independent third party has verified the trading history, the order book depth, or the funding rate mechanics that drove price convergence. Based on my experience building yield optimization scripts in DeFi Summer 2020, I know that a single market maker can significantly influence price discovery, especially in a low-liquidity environment.
The technical architecture is straightforward: IPOPs are perpetual swaps on Hyperliquid's L1 order book. The L1 is a custom chain with a centralized sequencer and validator set—a fact that the proposal does not highlight. The performance is high, but the trust assumption is centralized. The chain's security is the product's security. If the sequencer fails, the market stops.
What is more interesting is the convergence mechanism. IPOPs use a funding rate to align the perpetual price with the expected IPO price. As the IPO date approaches, arbitrageurs push the funding rate to force convergence. The claim that IPOPs discovered the "true" IPO price is a narrative artifact. What they discovered was the market's expectation of the underwriter's pricing—a different variable. Correlation is not causation. The price discovery claim is a marketing tool, not a forensic conclusion.
Contrarian: The Grey Zone Has No Exit
Here is the counter-intuitive angle: IPOPs are not a securities exchange, but they are also not a pure prediction market. Polymarket's event contracts involve binary outcomes (e.g., "Will candidate X win?"). IPOPs track a continuous price that is exactly the same as the underlying stock's eventual listing price. The SEC can argue that the price discovery function is inseparable from the security itself—that by providing a continuous price for a stock before it lists, IPOPs are effectively performing the role of a securities market. The fact that no shares are delivered is a legal formality, not a functional distinction.
The CFTC will likely claim jurisdiction as well. Event contracts fall under the CFTC's purview, and the CFTC has been aggressive in requiring no-action relief for prediction markets (e.g., Kalshi, Polymarket). IPOPs do not fit neatly into either agency's box. The dual jurisdiction is a structural weakness that no amount of comment letters can resolve without legislation.
Furthermore, the single market maker concentration is a red flag. trade[XYZ] is the sole operator of the five completed IPOP markets. In a crisis—such as a flash crash or a sudden withdrawal of liquidity—the market would collapse. The SEC's mandate includes market integrity. A centralized market maker in a decentralized wrapper is the worst of both worlds.
Takeaway: The Next Signal
Watch for two signals. First, the SEC's response: will it request additional data, issue a no-action letter, or propose rulemaking? Second, the CFTC's parallel action: if the CFTC asserts jurisdiction, the product will be forced into a regulatory bottleneck that limits U.S. access. The code didn't break—the architecture is sound. But the legal framework is a fault line. The next quarter will tell us whether DeFi can build yield in a vacuum of trust, or whether the old walls of Wall Street are too high to scale.
Signatures Tracing the hash that broke the ledger. Building yield in a vacuum of trust. Sifting noise to find the alpha signal.
